|
R&D Pipeline News Vol. 2, Issue 23: Update on Thrombopoiesis Stimulating Agents |
|
|
|
19 Jun 2006 |
Read the highlights of the most recent edition of our weekly R&D information product R&D Pipeline News. The Special Product or Technology Pipelines of R&D Pipeline News are available via subscription of R&D Pipeline News or as a single Project Pipeline List .
 |
| |
Special Target Pipelines:
Special Company Pipelines:
|
Vol. 2 Issue nº 23
June 19, 2006
|
 |
|
|
Special Target Pipeline:
|
Update on Thrombopoiesis Stimulating Agents
|
|
|
|
Special Company Pipelines
|
Dainippon Sumitomo Pharma Co. (Japan)
|
- Sales of US$ 1.686 bln. in fiscal year 2005/6;
- Predominantly small molecule projects;
- Increasingly development projects in overseas;
- New disease area focus on neurology & psychiatry and metabolism;
- Opportunistic projects in genitourinary, oncology, rheumatoid and pulmonary diseases;
- Licensing-out deals with Merck, Novartis, Eisai and Sunesis.
More Details inside R&D Pipeline News
Get you annual subscription and receive this issue for free!
|
|
R&D Pipeline News
Get your Subscription Now
|
R&D Pipeline News is a premier information source about research and development (R&D) projects in the pipeline of the biopharmaceutical industry and is directed to all stakeholders in R&D . R&D Pipeline News covers all relevant treatment modalities, including. drugs, medical devices, biomaterials, combination products, cell therapy and drug delivery products.
Read more about R&D Pipeline NewsOrder Now
 
|
|
|
|
|
|
|
|
|
